Ultra-Hypofractionated Radiation Therapy for Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Is Safe and Effective: 5-Year Outcomes of a Phase II Trial

BJU International - United Kingdom
doi 10.1111/bju.14925
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Wiley


Related search